COVID-19-associated hepatic artery pseudoaneurysms.
Michel DupuisMaxime RonotAsselah TarikSylvain BodardPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
Cases of coronary and pulmonary artery pseudoaneurysms secondary to COVID-19 have been reported in the literature and are supposed to be secondary to inflammatory and vasculitis processes linked to a viral multisystem inflammatory syndrome. Although the incidence of COVID-19-associated liver injury ranges from 14% to 53% in hospitalized patients, COVID-19-associated hepatic artery pseudoaneurysms have never been reported so far. We present the case of a patient whose follow-up CT after cryoablation of renal cell carcinoma revealed seven fusiform pseudoaneurysms of the two hepatic arteries secondary to COVID-19. Anticoagulant or anti-inflammatory treatments were not introduced. Vascular lesions were unchanged on the 3-month follow-up CT. At 6-month CT, the proximal pseudoaneurysm was replaced by a proximal occlusion of the accessory RHA.
Keyphrases
- sars cov
- coronavirus disease
- pulmonary artery
- liver injury
- coronary artery
- computed tomography
- drug induced
- image quality
- renal cell carcinoma
- respiratory syndrome coronavirus
- dual energy
- contrast enhanced
- anti inflammatory
- oxidative stress
- pulmonary hypertension
- magnetic resonance imaging
- systematic review
- pulmonary arterial hypertension
- case report
- coronary artery disease
- heart failure
- venous thromboembolism
- aortic stenosis